Philip He

Philip Philip possesses extensive experience in statistical strategy and innovation, currently serving as the Head of Statistical Strategy & Innovation at Daiichi Sankyo, Inc. Previously, Philip held key leadership roles at AstraZeneca as Sr. Director and Biometrics Team Lead in Immuno-Oncology, and at Celldex Therapeutics as Senior Director and Head of Statistics and Programming. Additional experience includes positions as Associate Director and Senior Manager in Oncology at Eisai US, and Senior Statistician specializing in Oncology at Sanofi. Philip earned a Doctor of Philosophy degree in Biostatistics from the University of Minnesota between 2002 and 2006.